PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 38 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,324,221 | -36.8% | 439,102 | +4.6% | 0.00% | -33.3% |
| Q2 2023 | $11,589,628 | +39.5% | 419,610 | +16.2% | 0.00% | 0.0% |
| Q1 2023 | $8,306,634 | +123.9% | 361,158 | +6.2% | 0.00% | +200.0% |
| Q4 2022 | $3,709,629 | +31.9% | 340,021 | +1.9% | 0.00% | 0.0% |
| Q3 2022 | $2,813,000 | +9.5% | 333,643 | +2.7% | 0.00% | 0.0% |
| Q2 2022 | $2,569,000 | -66.6% | 324,758 | -0.2% | 0.00% | -50.0% |
| Q1 2022 | $7,703,000 | -29.0% | 325,259 | +2.5% | 0.00% | -33.3% |
| Q4 2021 | $10,848,000 | +97.6% | 317,179 | +2.4% | 0.00% | +50.0% |
| Q3 2021 | $5,491,000 | -56.5% | 309,832 | +10.1% | 0.00% | -50.0% |
| Q2 2021 | $12,629,000 | +86.4% | 281,378 | +7.6% | 0.00% | +100.0% |
| Q1 2021 | $6,776,000 | +49.2% | 261,587 | +16.1% | 0.00% | 0.0% |
| Q4 2020 | $4,541,000 | +7.3% | 225,220 | +4.0% | 0.00% | 0.0% |
| Q3 2020 | $4,233,000 | +319.9% | 216,486 | +279.3% | 0.00% | – |
| Q2 2020 | $1,008,000 | +225.2% | 57,072 | +30.0% | 0.00% | – |
| Q1 2020 | $310,000 | +0.3% | 43,904 | +0.3% | 0.00% | – |
| Q4 2019 | $309,000 | -36.7% | 43,753 | +7.7% | 0.00% | – |
| Q3 2019 | $488,000 | +10.4% | 40,614 | +11.4% | 0.00% | – |
| Q2 2019 | $442,000 | +59.0% | 36,469 | +12.9% | 0.00% | – |
| Q1 2018 | $278,000 | -30.8% | 32,315 | +67.4% | 0.00% | – |
| Q4 2017 | $402,000 | +71.8% | 19,300 | +46.2% | 0.00% | – |
| Q3 2017 | $234,000 | +56.0% | 13,200 | 0.0% | 0.00% | – |
| Q2 2017 | $150,000 | -11.8% | 13,200 | 0.0% | 0.00% | – |
| Q1 2017 | $170,000 | -41.6% | 13,200 | 0.0% | 0.00% | – |
| Q4 2016 | $291,000 | – | 13,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |